Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors.
D001241:Aspirin / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D000242:Cyclic AMP / Q000652:urine; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy*; D006961:Hyperparathyroidism / Q000097:blood; D007213:Indomethacin / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009384:Paraneoplastic Endocrine Syndromes / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000097:blood; D011448:Prostaglandin Antagonists; D011458:Prostaglandins E / Q000652:urine
D010281:Parathyroid Hormone; D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D000242:Cyclic AMP; D001241:Aspirin; D002118:Calcium; D007213:Indomethacin